miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review

· · 5 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-glp1-gut`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-glp1-gut

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-glp1-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-glp1-gut/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-glp1-gut/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-glp1-gut/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have GLP-1 gut damage / gastroparesis

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why GLP-1 agonists (class) matters for you

  1. Drug: GLP-1 agonists (class)
  2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 6
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 6

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.55 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

GLP-1 Agonists and Gastrointestinal Adverse Events (source s3)

Observational study on GI risks including gastroparesis with GLP-1 agonists.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Elamipretide: A Review of Its Structure, Mechanism of Action ... (source s9)

Review of SS-31 mechanism via cardiolipin binding.

Evidence type: Published research.

Elamipretide - an overview (source s10)

Overview confirming mitochondrial targeting.

Evidence type: Published research.

SS-31 (also known as Elamipretide®...) Cognitive Vitality For Researchers (source s12)

Summary of human tissue and preclinical data.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Late-life restoration of mitochondrial function reverses ... (source s16)

Rodent study on mitochondrial restoration in aging heart.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy (source s28)

Human trial showing functional improvement in PMM.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

GLP-1 agonists · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence… · 2 humanSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc… · 2 humanSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid… · 2 humanSS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Rev… · 2 human
Evidence · 6 sources · swipe →chain 9885394fe8e8 · verify chain · provenance
1 / 6
Evidence ledger 5 · tier-ranked · API
human
No human trials have tested SS-31 in gastroparesis or GLP-1 gut damage.
mechanistic
SS-31 binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae and reducing ROS production.
sources: s9, s10
humanlow confidence
One randomized trial showed dose-dependent improvement in 6-minute walk distance in primary mitochondrial myopathy patients after 5 days of elamipretide.
sources: s28
humanlow confidence
GLP-1 agonist use was associated with adjusted HR 3.67 for gastroparesis versus comparator in an observational study.
sources: s3
preclinicallow confidence
SS-31 improved mitochondrial function in ex vivo failing human hearts and in rodent models of oxidative stress.
sources: s12, s16
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:54
SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review · 5 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Glp1 Gut
Slug: ss-31-glp1-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"GLP-1 gut damage / gastroparesis","condition_key":"glp1-gut-damage","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["glp1-agonists"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"secti
it output
{
  "slug": "ss-31-glp1-gut",
  "title": "SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review",
  "body": "## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 agonists slow gastric emptying as part of their metabolic action. In some people this effect becomes excessive and leads to symptoms of gastroparesis. The stomach and small intestine rely on smooth muscle cells and enteric neurons that need steady ATP from mitochondria to contract and coordinate movement. When mitochondria in these cells produce excess reactive oxygen species or lose efficient electron transport, energy drops and motility slows further. Oxidative damage to cardiolipin in the inner mitochondrial membrane can worsen cristae structure and ATP output. If your GLP-1 use coincides with persistent delayed emptying, one layer of the problem may be mitochondrial stress in gut tissue rather than only the drug's direct receptor effect. Repair pathways that target this mitochondrial layer differ from simply stopping the drug or masking symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in enteric smooth muscle or neurons is part of your problem, SS-31 (Elamipretide) is discussed because it targe
4029d62ee1ce2bf7
Machine verification: /api/articles/ss-31-glp1-gut/contributions

Related articles

GLP-1 agonists · drug map

Open evidence map →
Ss 31ss-31SS-31 (Elamipretide) for Benzodiazepine Withdrawal: Mitochondrial Repa…ss-31-benzo-withdrawalSS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a…ss-31-benzodiazepinesSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence…ss-31-brain-fogSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc…ss-31-carpal-tunnelSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid…ss-31-chemo
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials have tested SS-31 in gastroparesis or GLP-1 gut damage."?
ask ss-31-glp1-gut claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "SS-31 binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae and reducing ROS production."?
ask ss-31-glp1-gut claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "One randomized trial showed dose-dependent improvement in 6-minute walk distance in primary mitochondrial myopathy patients after 5 days of …"?
ask ss-31-glp1-gut claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "GLP-1 agonist use was associated with adjusted HR 3.67 for gastroparesis versus comparator in an observational study."?
ask ss-31-glp1-gut claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "SS-31 improved mitochondrial function in ex vivo failing human hearts and in rodent models of oxidative stress."?
ask ss-31-glp1-gut claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review — and what would you need me to tell you first?
ask ss-31-glp1-gut condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review (studies vs anecdotes)?
ask ss-31-glp1-gut good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…